Transcriptomic Evaluation of Cbfa1 Gene during Osteogenic Differentiation of Adipose Derived Mesenchymal Stem Cells

Document Type : Original Article (s)

Authors

1 PhD Student, Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Faculty Member, Iranian Academic Center for Education Culture and Research, Markazi Branch, Arak, Iran

3 Assistant Professor, Department of Anatomy and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Associate Professor, Department of Anatomy and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

5 PhD Student, Department of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

6 MSC Student, Department of Anatomy and Molecular Biology, School of Medicine AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Bone is a tissue with high repair capacity; but, this ability dramatically is limited during irrecoverable bone and skeletal defects. Stem cell therapy is a promising approach for construction of bone tissue. Mesenchymal stem cells (MSCs) have been introduced as basic tools for bone tissue generation in tissue engineering. Core binding factor alpha 1 (Cbfa1) is one of the main genes involved in osteogenesis. Since relative expression of Cbfa1 in differentiated osteoblasts from adipose derived stem cells is unknown, this study aimed to evaluate the gene expression pattern of Cbfa1 in adipose derived differentiated osteoblasts in 4 different time intervals.Methods: Real-time PCR was used for studying the gene expression of Cbfa1 in human normal osteoblasts and adipose derived osteogenic osteoblasts at the days 7, 14, 21 and 28.Findings: There was a progressive increase in Cbfa1 expression over the differentiation period of adipose derived mesenchymal stem cells (ADSCs) from day 7 to day 28. Differentiated osteoblasts expressed Cbfa1 lower than native osteoblasts (P < 0.05).Conclusion: ADSCs are an attractive source for engineering a new bone tissue. According to our results, adipose derived differentiated osteoblasts express candidate gene at least on day 7 of culture. Our study indicates that longer treatment of ADSCs in osteogenic medium confer better osteoblastic properties to these cells.

Keywords

References

  1. Dallari D, Fini M, Stagni C, Torricelli P, Nicoli AN, Giavaresi G, et al. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res 2006; 24(5): 877-88.
  2. Kim WS, Vacanti CA, Upton J, Vacanti JP. Bone defect repair with tissue-engineered cartilage. Plast Reconstr Surg 1994; 94(5): 580-4.
  3. Rodan GA. Introduction to bone biology. Bone 1992; 13(Suppl 1): S3-S6.
  4. Alsberg E, Anderson KW, Albeiruti A, Franceschi RT, Mooney DJ. Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res 2001; 80(11): 2025-9.
  5. de Boer HH. The history of bone grafts. Clin Orthop Relat Res 1988; (226): 292-8.
  6. Gazdag AR, Lane JM, Glaser D, Forster RA. alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg 1995; 3(1): 1-8.
  7. Green SA, Jackson JM, Wall DM, Marinow H, Ishkanian J. Management of segmental defects by the Ilizarov intercalary bone transport method. Clin Orthop Relat Res 1992; (280): 136-42.
  8. Ikada Y. Challenges in tissue engineering. J R Soc Interface 2006; 3(10): 589-601.
  9. Kaigler D, Mooney D. Tissue engineering's impact on dentistry. J Dent Educ 2001; 65(5): 456-62.
  10. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260(5110): 920-6.
  11. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994; 56(3): 283-94.
  12. Aubin JE. Bone stem cells. J Cell Biochem Suppl 1998; 30-31: 73-82.
  13. Shui C, Spelsberg TC, Riggs BL, Khosla S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 2003; 18(2): 213-21.
  14. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-95.
  15. Kirkham GR, Cartmell SH. Genes and proteins involved in the regulation of osteogenesis. In: Ashammakhi N, Ferretti P, editors. Topics in tissue engineering. 1st. Oulu, Finland: University of Oulu; 2003.
  16. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89(5): 747-54.
  17. Araki S, Mezawa M, Sasaki Y, Yang L, Li Z, Takai H, et al. Parathyroid hormone regulation of the human bone sialoprotein gene transcription is mediated through two cAMP response elements. J Cell Biochem 2009; 106(4): 618-25.
  18. Sila-Asna M, Bunyaratvej A, Maeda S, Kitaguchi H, Bunyaratavej N. Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell. Kobe J Med Sci 2007; 53(1-2): 25-35.
  19. Banerjee C, Javed A, Choi JY, Green J, Rosen V, van Wijnen AJ, et al. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 2001; 142(9): 4026-39.
Journal of Isfahan Medical School
Volume 31, Issue 236 - Serial Number 236
March and April 2013
Pages 640-648

Files

History

  • Receive Date: 22 May 2013
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics